eMagin Stock

eMagin Quick Ratio

Delisted

The Quick Ratio (Acid Test) of eMagin (EMAN) as of Aug 9, 2026 is 1.41. In the previous year, Quick Ratio (Acid Test) was 0.99 — a change of 43.22% (higher).

Quick Ratio

1.41

YoY

43.22%

Last updated:

Quick Ratio (Acid Test) of eMagin is 2026 1.41 . Quick Ratio (Acid Test) of eMagin was 2025 0.99 . It decreases by 43.22% higher compared to the previous year.
Access this data via the Eulerpool API

eMagin Stock analysis

What does eMagin do? eMagin Corp is a company that specializes in the development of OLED microdisplays. The company was founded in 1993 and has since developed a wide range of products, ranging from screens and projections to virtual reality and augmented reality applications. The business model of eMagin Corp is focused on providing customized OLED microdisplays and subsystems for both military and civilian applications. The company's headquarters is located in Hopewell Junction, New York, while its production facilities are located in the United States and South Korea. The company is listed on the NASDAQ stock index. In the early years of the company, eMagin mainly focused on the development of OLED microdisplays for military applications. However, it later expanded into other areas such as virtual and augmented reality displays and content, with a focus on the combination of OLED technology and precise image processing. The company has received numerous patents and awards, including the prestigious Innovation Award from the US Department of Defense. eMagin Corp also has strategic partnerships with other high-tech companies to develop synergistic products and services. The product divisions of eMagin include: - Military applications: The company offers OLED microdisplays for use in night vision devices, weapon systems, and aircraft. - Security: eMagin Corp provides advanced OLED microdisplays to the police and other authorities for better surveillance and control of surveillance cameras and other devices. - Medical imaging: In collaboration with leading medical technology companies, eMagin develops displays for medical imaging devices that offer higher resolution and precision than conventional technologies. - Entertainment: The company offers OLED microdisplays for VR headsets and AR glasses to enable high-quality gaming and entertainment experiences. eMagin Corp has a future-oriented strategy to continue developing innovative products and services and improving existing technologies. This includes the use of OLED technology, processing and transmission of 3D images, and the integration of eye-tracking technologies in VR and AR applications. In conclusion, eMagin Corp plays an important role in the development of OLED microdisplays used in various products and services. With its innovative strategy and numerous patents and awards, the company is expected to continue to maintain a leading position in the industry. eMagin is one of the most popular companies on Eulerpool.

Frequently Asked Questions about eMagin stock

Quick Ratio (Acid Test) of eMagin is 1.41 in 2026.

Quick Ratio (Acid Test) of eMagin changed from 0.99 to 1.41, representing a 43.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) eMagin since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s eMagin with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — eMagin

All Key Metrics — eMagin